Singapore
Lonza will expand its Singapore biomanufacturing campus in the Tuas Biomedical Park with the addition of 21,528 sf of laboratory space. The $11.3 million expansion will support cell line development, processing, and analytical services. Completion is expected in 2012. Lonza is a life sciences company based in Switzerland.
